SCHEMBL3255024

SCHEMBL3255024

Cc1ccc(OCCCO)cc1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 6/20 0.59
DRD4 P21917 6/20 0.59
DRD3 P35462 6/20 0.59
L3MBTL1 Q9Y468 1/20 0.57
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
KCNH2 Q12809 2/20 0.50
NPC1 O15118 1/20 0.49
WDR5 P61964 1/20 0.48
ALDH1A1 P00352 2/20 0.48
PKM P14618 1/20 0.48
TSHR P16473 1/20 0.48
KDM4E B2RXH2 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18071260 0.94 DRD2 (0.53) DRD2DRD4DRD3L3MBTL1MEN1
SCHEMBL1374364 0.93 DRD2 (0.57) DRD2DRD4DRD3L3MBTL1MEN1
SCHEMBL18643854 0.91 DRD2 (0.55) DRD2DRD4DRD3L3MBTL1MEN1
SCHEMBL18643855 0.91 DRD2 (0.55) DRD2DRD4DRD3L3MBTL1MEN1
SCHEMBL13572532 0.91 DRD2 (0.55) DRD2DRD4DRD3L3MBTL1MEN1
SCHEMBL8955642 0.91 DRD2 (0.55) DRD2DRD4DRD3L3MBTL1MEN1
SCHEMBL26116498 0.91 DRD2 (0.55) DRD2DRD4DRD3L3MBTL1MEN1
SCHEMBL2806021 0.91 DRD2 (0.55) DRD2DRD4DRD3L3MBTL1MEN1
SCHEMBL13945546 0.89 DRD2 (0.49) DRD2DRD4DRD3L3MBTL1MEN1
P-Xylene SCHEMBL6845696 0.88 ALDH1A1 (0.60) DRD2DRD4DRD3L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023088493-A1 FURO-PYRIDONE COMPOUND AND USE THEREOF 中国科学院广州生物医药与健康研究院 2023-05-25 WO disclosed
US-11538992-B2 Formulation of an organic functional material MERCK PATENT GMBH (DE) 2022-12-27 US disclosed
EP-3532565-B1 FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL MERCK PATENT GMBH (DE) 2021-04-21 EP disclosed
US-20200127203-A1 FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL MERCK PATENT GMBH (DE) 2020-04-23 US disclosed
WO-2018102725-A1 TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS Arvinas, Inc. (US) 2018-06-07 WO disclosed
WO-2018077660-A1 FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL MERCK PATENT GMBH (DE) 2018-05-03 WO disclosed
US-9758502-B2 Dihydropyrone compounds and herbicides comprising the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-09-12 US disclosed
EP-2727947-B1 COPOLYMER, AND LIQUID CRYSTAL ALIGNMENT LAYER COMPRISING HARDENED PRODUCT THEREOF DAINIPPON INK & CHEMICALS (JP) 2017-03-15 EP disclosed
US-9328076-B2 Molecular glasses with functionalizable groups HER MAJESTY IN THE RIGHT OF CANADA AS REPRESENTED BY THE MINISTER OF DEFENSE (CA) 2016-05-03 US disclosed
US-20150299156-A1 DIHYDROPYRONE COMPOUNDS AND HERBICIDES COMPRISING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-22 US disclosed
US-20070082933-A1 Novel thiazolidin-4-one derivatives ACTELION PHARMACEUTICALS, LTD. 2007-04-12 US disclosed
US-20070082933-A1 Novel thiazolidin-4-one derivatives ACTELION PHARMACEUTICALS, LTD. 2007-04-12 US disclosed
CN-1286865-C Plastic lens composition plastic lens and process for producing the plastic lens SHOWA DENKO KK (JP) 2006-11-29 CN disclosed
WO-2006030032-A1 NOVEL PYRIDINONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2-RECEPTORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-03-23 WO disclosed
WO-2005054215-A1 5-(BENZ- (Z) -YLIDENE) -THIAZOLIDIN-4-ONE DERIVATIVES AS IMMUNOSUPPRESSANT AGENTS ACTELION PHARMACEUTICALS LTD (CH) 2005-06-16 WO disclosed
US-5147884-A Microbiocide mixture containing tert-butyl hydroperoxide, a monophenylglycol ether and a diluent; discoloration inhibition, controlling consistency and preventing odor STERLING DRUG INC. (US) 1992-09-15 US disclosed
EP-0275203-A2 Heat-sensitive recording material containing color forming components FUJI PHOTO FILM CO., LTD. (JP) 1988-07-20 EP disclosed
US-4485043-A Process for producing 1-amino-4-hydroxy-anthraquinones CIBA-GEIGY AG (CH) 1984-11-27 US disclosed
US-4415494-A BLUE-TO-BLACK COLORFAST DISPERSE, NITRO DYES; DIAZOTIZING A P-NITROANILINE AND COUPLING WITH AN N-SUBSTITUTED 1-NAPHTHYLAMINE CASSELLA AKTIENGESELLSCHAFT (DE) 1983-11-15 US disclosed
EP-0036545-A1 Water insoluble monoazo dyes, their preparation and their use CASSELLA Aktiengesellschaft (DE) 1981-09-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150299156-A1 DIHYDROPYRONE COMPOUNDS AND HERBICIDES COMPRISING THE SAME CBR3, DDT, WEE2 DRD2 855/4885DRD4 748/4885DRD3 821/4885
US-20070082933-A1 Novel thiazolidin-4-one derivatives TLR4, IL4, IRF3 DRD2 2868/4885DRD4 1309/4885DRD3 2371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.